Nipro (TSE:8086) NonCurrent Deferred Liabilities: 円0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:8086 Nipro Corp TSE:8086
72 GF Score
Price 円1,628.00
GF Value 円1,466.11
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nipro NonCurrent Deferred Liabilities?

Nipro TSE:8086 +3.69% 72 NonCurrent Deferred Liabilities is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:8086 with a GF Score™ of 72/100 and a GF Value™ of 円1,466.11 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Nipro's non-current deferred liabilities for the quarter that ended in Mar. 2026 was 円0 Mil.

Nipro NonCurrent Deferred Liabilities Related Terms

Nipro NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Nipro's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro NonCurrent Deferred Liabilities Chart

Nipro Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nipro Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:8086
72GF Score
Nipro Corp TSE:8086
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of 円0 Mil mean?
Nipro (TSE:8086) has a NonCurrent Deferred Liabilities of 円0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Nipro and its competitors.
Is Nipro's NonCurrent Deferred Liabilities too high?
Nipro's current NonCurrent Deferred Liabilities is 円0 Mil. Overall, Nipro has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nipro's NonCurrent Deferred Liabilities compare to ISRG and BDX?
Nipro's NonCurrent Deferred Liabilities of 円0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Nipro and its competitors. Nipro's current NonCurrent Deferred Liabilities is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (TSE:8086) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,466.11, compared to a current price of 円1,628.00 — trading 11% above its estimated fair value. The current NonCurrent Deferred Liabilities is 円0 Mil. Nipro's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Nipro (TSE:8086), the current NonCurrent Deferred Liabilities is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nipro (TSE:8086) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be overvalued. The current stock price of 円1,628.00 is trading 11% above its estimated GF Value™ of 円1,466.11. GuruFocus considers Nipro to be Modestly Overvalued.

Key valuation signals for TSE:8086:

  • NonCurrent Deferred Liabilities: 円0 Mil
  • GF Value™: 円1,466.11 vs. price of 円1,628.00 (11% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the TSE:8086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nipro Business Description

Other Exchanges 5FA:Germany
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
72GF Score

Get the complete analysis for TSE:8086

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,628.00
Price
円1,466.11
GF Value